Ra Medical Systems Inc

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Catheter Precision, Inc. engages in the design, manufacture and sale of medical devices and technologies for cardiac electrophysiology. It offers the Amigo Remote Catheter System for accurate positioning, manipulation, and stable control of catheters for use by electrophysiologists in the diagnosis and treatment of abnormal heart rhythms. The company was founded by David Jenkins in September 2002 and is headquartered in Fort Mill, SC.

Medtronic

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems announces definitive merger agreement with Precision Catheter.

Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that on August 31, 2022, it received a notice (the “Notice”) that the NYSE American LLC has determined the Company's securities have been selling at a low price per share for a substantial period of time. Pursuant to Section 1003(f)(v) of the NYSE American Company Guide, the Company's continued listing is predicated on it effecting a reverse stock split of its common stock

Ra Medical Systems Receives NYSE American Notice

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Ra_Medical--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”) reports financial results for the three and six months ended June 30, 2022 and provides a business update. “We are continuing to pursue a potential merger with a privately held company, Catheter Precision, Inc., (“Catheter Precision”) which would give our shareholders exposure to Catheter Precision's innovative medical devices to improve the treatment of cardiac arrhythmias while al

Ra Medical Systems Reports Second Quarter 2022 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company's Form 10-K filed with the Securities and Exchange Commission (SEC) on March 24, 2022 and Amended Form 10-K/A filed with the SEC on July 7, 2022 contained an audit report from its independent registered public accounting firm which included a going concern

Ra Medical Systems Provides Update on its Annual Filings

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company) announces a reduction in the exercise price of all existing warrants that were issued in the February 2022 public offering, consisting of Series A Warrants and Series B Warrants, from $0.50 per share to $0.28 per share, and entry into a non-binding term sheet to merge with privately held Catheter Precision Inc. (“Catheter Precision”). On July 22, 2022, Ra Medical entered into warrant

Ra Medical Systems Enters Into Agreements to Raise $6.2 Million Through Previously Issued Warrants and Plans Strategic Merger with Catheter Precision Inc.

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or the “Company”), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Officer, effective immediately. Mr. Conn will serve as the Company's Principal Financial Officer and Principal Accounting Officer. Mr. Conn has served as a consultant to Ra Medical since May 25, 2022. He replaces

Ra Medical Systems Appoints Brian D. Conn Interim Chief Financial Officer

Ra Medical (RMED) stock is rocketing higher on Tuesday after the medical device company got an update from the FDA for its new catheter. The post Why Is Ra Medical (RMED) Stock Up 65% Today?

Why Is Ra Medical (RMED) Stock Up 65% Today?

Tyme Technologies

Endo International

Titan Pharma

Penny stocks to watch with news The post Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving

The FDA has cleared RA Medical Systems Inc's (NYSE: RMED) DABRA 2.0 catheter as part of the DABRA Excimer Laser System.  This next-generation DABRA catheter features enhancements, including a braided over jacket design intended to improve deliverability and kink resistance.

Why Ra Medical Systems Shares Are Trading Higher Today?

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #Atherectomy--Ra Medical Systems receives FDA clearance for DABRA 2.0 catheter.

Ra Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 Catheter

Ra Medical Systems, Inc. (NYSE:RMED ) Q1 2022 Earnings Conference Call May 16, 2022 4:30 PM ET Company Participants Bruce Voss - LHA Will McGuire - Chief Executive Officer Andrew Jackson - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Good day, and welcome to the Ra Medical Systems First Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q1 2022 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) (“Ra Medical” or “the Company”), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months ended March 31, 2022 and provides a business update. Recent Operational Highlights Business and operational highlights from the first quarter of 2022 and recent weeks include the following: Increased enrollment to 107 subjects and opened

Ra Medical Systems Reports First Quarter 2022 Financial Results

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration   Participants can pre-register for the conference call here:           Callers w

Ra Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser ablation catheters with expanded distal optical windows. U.S. patent 11,284,941 (the '941 patent), titled Laser Ablation Catheters Having Expanded Distal Tip Windows for Efficient Tissue Ablation, descr

Ra Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation Area

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment of 100 subjects in its pivotal clinical study to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). This pivotal atherectomy study is cleared to enroll

Ra Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical Study

Ra Medical Systems, Inc. (RMED) CEO Will McGuire on Q4 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full year ended December 31, 2021 and provides a business update. Recent Operational Highlights Filed 510(k) application with the FDA for our next-generation DABRA catheter that incorporates a braided overjacket designed to improve robustness and includes data supp

Ra Medical Systems Reports 2021 Fourth Quarter and Full Year Financial Results

Bone Biologics Corp

Humanigen

Kiora Pharmaceuticals

Biotech penny stocks to watch right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 4 Biotech Stocks To Watch Right Now

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update. Pre-Registration   Participants can pre-register for the conference call here           Callers who p

Ra Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022

AnPac Bio-Medical Science Co

Jaguar Health

Exela Technologies

Reddit penny stocks under $1 to watch this week. The post 5 Penny Stocks Under $1 To Buy According To Redditors This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Penny Stocks Under $1 To Buy According To Redditors This Week

iQIYI

Kaival Brands Innovations Group

Check these three penny stocks out for your March watchlist The post Buying Penny Stocks in March 2022? Check These 3 Out  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Buying Penny Stocks in March 2022? Check These 3 Out

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the filing of a 510(k) application with the U.S. Food and Drug Administration (FDA) for the company's next-generation DABRA catheter with a braided overjacket and a six-month shelf life as a device for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular d

Ra Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf Life

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its pivotal clinical trial to evaluate the safety and effectiveness of the DABRA excimer laser system as an atherectomy device for the treatment of peripheral arterial disease (PAD). The company also announces approval from the U.S. Food and Drug Administration (FDA)

Ra Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical Trial

Citius Pharmaceuticals

Outlook Therapeutics Inc

Biotech penny stocks to watch as Ukraine-Russia conflict builds steam. The post Biotech Penny Stocks To Buy For Under $5 As Russia Ukraine Conflict Heats Up appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Biotech Penny Stocks To Buy For Under $5 As Russia Ukraine Conflict Heats Up

CARLSBAD, Calif.--(BUSINESS WIRE)---- $RMED #PAD--Ra Medical Systems awarded U.S. patent for support catheter for use supporting a liquid core ablation catheter

News for Ra Medical Systems Inc Stock (RMED)